Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study

Itokawa Norio; Atsukawa Masanori; Tsubota Akihito; Okubo Tomomi; Arai Taeang; Nakagawa Ai; Kondo Chisa; Iwakiri Katsuhiko

首页> 外文期刊>International journal of clinical oncology >Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study

【24h】

Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study

机译：索拉非尼联合小剂量干扰素治疗晚期肝细胞癌的临床研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Sorafenib is a standard of care for advanced hepatocellular carcinoma (HCC). An in vitro study showed the synergistic effects of sorafenib and interferon for HCC. To clarify the efficacy, combination therapy with sorafenib and interferon was performed for patients with advanced HCC.

机译：索拉非尼是晚期肝细胞癌（HCC）的护理标准。一项体外研究显示索拉非尼和干扰素对肝癌具有协同作用。为了阐明疗效，对晚期肝癌患者进行了索拉非尼和干扰素联合治疗。

著录项

来源
《International journal of clinical oncology》 |2016年第4期|共8页
作者
Itokawa Norio; Atsukawa Masanori; Tsubota Akihito; Okubo Tomomi; Arai Taeang; Nakagawa Ai; Kondo Chisa; Iwakiri Katsuhiko;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Hepatocellular carcinoma; Sorafenib; Pegylated interferon; Vascular endothelial growth factor; alpha-Fetoprotein;

机译：肝细胞癌;索拉非尼;聚乙二醇干扰素;血管内皮生长因子;甲胎蛋白;

相似文献

外文文献
中文文献
专利

1. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study [J] . Itokawa Norio, Atsukawa Masanori, Tsubota Akihito, International journal of clinical oncology . 2016,第4期

机译：索拉非尼联合小剂量干扰素治疗晚期肝细胞癌的临床研究
2. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study [J] . Jian-Dong Zhao, Jin Liu, Zhi-Gang Ren, Radiation oncology . 2010,第1期

机译：局部晚期肝细胞癌患者三维共形放射治疗/强度调制放射治疗与经导管动脉化疗栓塞联合治疗后索拉非尼的维持：I / II期研究
3. Pilot Study of Hepatic Arterial Infusion Chemotherapy with Interferon-beta and 5-fluorouracil: A New Chemotherapy for Patients with Advanced Hepatocellular Carcinoma [J] . Satoshi Shakado, Kaoru Iwata, Naoaki Tsuchiya, Hepato-gastroenterology. . 2014,第131期

机译：干扰素-β和5-氟尿嘧啶对肝动脉灌注化疗的初步研究：晚期肝细胞癌患者的新型化疗
4. Evaluation of the Effects of Themotherapy Combined with Chemotherapyin Treating Gastro-intestinal Advanced Carcinoma or with Metastatic Cancer [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：热疗法联合化学疗法治疗胃肠道晚期癌或转移性癌的疗效评估
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread: A prospective cohort study [O] . Masahito Nakano, Takashi Niizeki, Hiroaki Nagamatsu, -1

机译：碘油顺铂悬浮液联合5-氟尿嘧啶与索拉非尼动脉内输注治疗晚期肝细胞癌并伴有大范围血管侵犯且无肝外扩散的前瞻性队列研究
7. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study [O] . Jian-Dong Zhao, Jin Liu, Zhi-Gang Ren, 2010

机译：局部晚期肝细胞癌患者三维共形放射治疗/强度调节放射治疗与经导管动脉化疗栓塞联合治疗后索拉非尼的维持：I / II期研究

Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study

摘要

著录项

相似文献

相关主题

期刊订阅